(Q74452504)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

cerebrotendinous xanthomatosis

10 November 2019

main subject

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

A Verrips

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B G Van Engelen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Keyser

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B G Wolthers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

F Barkhof

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Stalenhoef

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R De Graaf

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

F Janssen-Zijlstra

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Van Spreeken

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

F J Gabreëls

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

233-238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

Low-density lipoprotein metabolism in cerebrotendinous xanthomatosis

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous Xanthomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Cerebrotendinous xanthomatosis: a family study of sterol 27-hydroxylase mutations and pharmacotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Cerebrotendinous xanthomatosis in two sisters: case reports and MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Exon skipping in the sterol 27-hydroxylase gene leads to cerebrotendinous xanthomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Magnetic resonance imaging in cerebrotendinous xanthomatosis: a prospective clinical and neuroradiological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Familial defective apolipoprotein B-100 (FDB): effect of simvastatin therapy on LDL-receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Treatment of cerebrotendinous xanthomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990040-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0026-0495(99)90040-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10024088%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference